Observational study of neuroinflammation diseases in China

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate structural and functional changes in the brain and spinal cord of patients with neuroinflammatory and demyelination diseases using advanced MRI techniques. Participants will undergo various MRI scans, including double inversion recovery and diffusion kurtosis imaging, over a one-year follow-up period. The goal is to better understand the inflammatory environment and its impact on disease progression and disability. This observational approach will help identify key biomarkers and imaging characteristics associated with these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 16-75
* Diagnosis of neuroinflammatory and demyelination disease
* Availability of demographic and clinical data at the time disease onset
* Informed written consent obtained from the patient, and/or patient's parent(s), and/or legal representative. Assent, if old enough to grant, will be obtained from all patients under the age of 16 years.

Exclusion Criteria:

* Patients for whom MRI is contra-indicated
* Patients included in an ongoing clinical trial where the product is blinded

Where it's running

• Beijing Tiantan Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Principal investigator: Yaou Liu, PhD — Beijing Tiantan Hospital
• Study coordinator: Yaou Liu, PhD
• Email: yaouliu80@163.com
• Phone: +86 1059975396

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing genetic variations in patients with neuromyelitis optica and multiple sclerosis

  This study is trying to see if certain genetic differences in the FCGR3A gene are more common in Italian adults with neuromyelitis optica, MOGAD, or multiple sclerosis.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma, Roma · NCT06865274

• AI-assisted care for Multiple Sclerosis

  This study is testing whether using AI can help doctors better diagnose and treat people with Multiple Sclerosis by analyzing real-world data.

  Recruiting at 3 sites icometrix · Prague, Praha 2 and 2 other locations · NCT06280755

• Treadmill-based virtual reality walking training for MS patients

  This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.

  Recruiting Shepherd Center, Atlanta GA · Atlanta, Georgia · NCT07927439

• Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS

  This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.

  Recruiting Cairo University · Giza, Giza Governorate · NCT07918339

• REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care

  This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.

  Recruiting Imperial College London · London and 2 other locations · NCT07899502

• Tolebrutinib in real-world MS care for patients treated by clinicians

  This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.

  Recruiting Sanofi · Marina, Abu Dhabi Emirate · NCT07898371

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.